@article {1302186,
	title = {Tacrolimus Optic Neuropathy},
	journal = {J Neuroophthalmol},
	volume = {38},
	number = {2},
	year = {2018},
	month = {2018 Jun},
	pages = {160-166},
	abstract = {BACKGROUND: Tacrolimus (FK506, Prograf) is a potent immunosuppressant, which inhibits cytokine synthesis and blocks T-cell development. Optic neuropathy from tacrolimus toxicity is very uncommon but, when present, can result in severe vision loss.

METHODS: Case series and review of the literature.

RESULTS: We present 3 patients with tacrolimus optic neuropathy after bone marrow transplantation complicated by graft-vs-host disease and demonstrate the differing clinical and radiologic presentation of this presumed toxic optic neuropathy.

CONCLUSIONS: Tacrolimus optic neuropathy can manifest in a multitude of clinical presentations and can have devastating visual consequences.},
	issn = {1536-5166},
	doi = {10.1097/WNO.0000000000000635},
	author = {Rasool, Nailyn and Boudreault, Katherine and Lessell, Simmons and Prasad, Sashank and Cestari, Dean M}
}
